Navigation Links
March of Dimes Honors Dr. Susan Carlson for Outstanding Work In Maternal-Fetal Nutrition
Date:10/26/2008

WHITE PLAINS, N.Y., Oct. 27 /PRNewswire-USNewswire/ -- A doctor who is internationally recognized for her work in maternal-fetal nutrition, and specifically for research on DHA, an omega-3 fatty acid, has received the March of Dimes Agnes Higgins Award for outstanding achievement in the field of maternal-fetal nutrition.

Susan E. Carlson, Ph.D., was among the first to report that infants receiving breast milk had higher DHA (dietary docosahexaenoic acid) levels than formula-fed infants and the first to recognize and study the potential implications of this observation. Subsequently, her group was the first to report, in 1989, that formula-fed preterm infants had higher visual acuity when fed a formula containing DHA. DHA plays a crucial role in the growth and development of the central nervous system as well as visual functioning in infants and supports healthy brain development, especially in young children. Dr Carlson and her collaborators continue to actively study the role of DHA during fetal and neonatal development.

Dr. Carlson, the A.J. Rice Professor of Nutrition in the Department of Dietetics and Nutrition, Professor of Pediatrics at the University of Kansas Medical Center, and Clinical Professor of Obstetrics and Gynecology at the University of Missouri-Kansas City, was presented with the $3,000 award this evening at the annual meeting of the American Public Health Association (APHA) in San Diego, Calif.. The ceremony took place during a joint session of the APHA's Food and Nutrition and Maternal-Child Health sections.

In 2002, Dr. Carlson was awarded honorary membership in the American Dietetic Association for her pioneering work leading to the recognition that DHA was an essential nutrient for infants. Since that time, she has taken an active role in the education of pediatricians, obstetricians, nurses and dieticians about the roles of DHA in maternal and

infant health. She also has been involved nationally and interna
'/>"/>

SOURCE March of Dimes
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening
2. U.S. Census Bureau Daily Feature for March 11
3. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
4. Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
5. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
6. Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting
7. Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants
8. Interleukin Genetics Wins International Award for Outstanding Research Published in the Journal, Nutrition
9. Trojan(R) and the National Sexuality Resource Centers Campaign for Sexual Literacy Recognize Outstanding College Reporting on Sexual Health
10. Clinical Study Results: Nutrition 21s Iceland Health(R) Chromax(R) Chromium Picolinate Reduces Hunger, Food Intake and Cravings
11. Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)ACTON, Mass., Dec. 3 Allen Medical Systems, a subsidiary of Hill-Rom Holdings, Inc. (NYSE: HRC ), today announced the launch of its new Allen Amatech(TM) OEM (Original Equipment Manufacturer) busin
(Date:12/3/2009)MADISON, N.J., Dec. 3 A genetic variation that may indicate a patient,s risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is
(Date:12/3/2009)DOYLESTOWN, Pa., Dec. 3 Ted Karkus, Chairman and CEO of The Quigley Corporation, (Nasdaq: QGLY ) www.quigleyco.com announced today that the Company has completed its evaluation of its opportunitie
Breaking Medicine Technology:Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Your Surroundings Mirror Your Beliefs 50509 1Your Surroundings Mirror Your Beliefs 50509 2Your Surroundings Mirror Your Beliefs 50509 3Morphotek 28R 29 Inc Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and 12866 1Morphotek 28R 29 Inc Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and 12866 2Morphotek 28R 29 Inc Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and 12866 3eCardio Receives Significant Investment in Private Funding from Sequoia Capital 50507 1eCardio Receives Significant Investment in Private Funding from Sequoia Capital 50507 2
(Date:12/5/2009)WASHINGTON, Dec. 5 ,, What: Cuts for a Cause ,, Why: To make a difference in the fight against cancer and other terminal illnesses affecting children. All proceeds from each hair service given
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- ...d asthma can have bad reactions to certain holiday...ent sneezing and wheezing, according to the Americ...I). , Those who are allergic to live evergreens ma...oth live and artificial trees can trigger symptoms...
(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2
...identified particular genes that are most prone to... called DNA promoter hypermethylation. Hy...ch support normal cell development, to generate pr...anism and causes of hypermethylation, particularly...
...ion between an extreme form of sleep disorder, REM...mentia or parkinsonism. Patients with RBD...body dementia, Parkinsons disease or multiple syst... of researchers led by Bradley Boeve at Mayo Clini...
...husiasts and experts in the capital are strongly o... Reacting to recent reports of yet another appl...s here feel that the very idea of patenting knowle...nal. The entire issue of patenting is very corpora...
...verage for mental illness does not increase usage ...s who have children with mental illness, a Yale S...lth Services Research. Prior research has ...t professor in the Department of Epidemiology & Pu...
... dangers of the rugby scrum could be a key reason ...uffered by rugby players, says a researcher writi...s, although rare, are a major cause of permanently...by Union in partnership with the Accident Compensa...
...r quacks either. A team of researchers in Pennsylv... follicles . And they have successfully created n...nal Nature, they say hair growth can actually be e...hese follicles are produced by the embryo in the f...
Other Medicine News:Health News:Researchers Have Identified Cancer Promoter Genes 2Health News:Researchers Find Link Between Sleep Disorder and Dementia 2Health News:Yoga Enthusiasts Oppose Patenting Yoga Overseas 2Health News:Coverage for Childrens Mental Illness Reduces Out-of-Pocket Spending 2Health News:Innovative Education Scheme Sees Fewer Rugby Players Suffering Spinal Injuries 2Health News:It is Possible Reverse Hair Loss, US Scientists Say 2
...agnostics Histoplasma DxSelect is intended for qua...sulatum var. capsulatum in human serum. The test i... respiratory disease, as an aid in the presumptive...is test is not intended for self-testing, and this...
...unofluorescent antibody (IFA) test for the detecti...dies to St. Louis Encephalitis (SLE), Western Equi... (EEE), and California Encephalitis/La Crosse (CE)...s with fixed individual spots of SLE, WEE, EEE, an...
Epstein-Barr Nuclear Antigen (EBNA) ACIF (Anti-Complement Immunofluorescence)
CMF OL1000 Bone Growth Stimulators
Medicine Products: